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Abstract: The utilization of natural gum polysaccharides as the vehicle for drug delivery systems
and other biomedical applications has increased in recent decades. Their biocompatibility, biodegrad-
ability, and price are much cheaper than other materials. It is also renewable and available in massive
amounts, which are the main reasons for its use in pharmaceutical applications. Gum can be easily
functionalized with other natural polymers to enhance their applications. Various aspects of the uti-
lization of natural gums in the forms of polyelectrolyte complexes (PECs) for drug delivery systems
are discussed in this review. The application of different mathematical models were used to represent
the drug release mechanisms from PECs; these models include a zero-order equation, first-order
equation, Higuchi, simplified Higuchi, Korsmeyer–Peppas, and Peppas–Sahlin.
Keywords: gum polysaccharides; drug delivery; polyelectrolyte complexes; hydrocolloid
1. Introduction
One of the most abundant materials on our planet is polysaccharides; they are cheap,
found everywhere, and sustainable. The sources of polysaccharides are plants or animals.
Polysaccharides have repetitive structures of monosaccharides and are classified according
to their biological functions [1]:
• Plants: cellulose, hemicellulose, starch, pectin, gum.
• Marine algae: alginate, carrageenan, cellulose.
• Crustaceans: chitin.
Polysaccharides are utilized for various applications, and a promising one is a vehicle
for drug delivery systems. From 2010 to 2020, many papers focusing on using polysaccha-
rides as a drug delivery were published in various scientific journals. The main reasons for
increasing the interest of scientists in this area are its biocompatibility, biodegradable, much
cheaper than other materials, renewable, and its availability in massive amounts. Further-
more, different types of polysaccharides and their functionalization also give different
behaviors of drug delivery and release.
Polysaccharides as natural polymers have a hydrocolloid behavior, which can form a
gel at a specific temperature and/or in the presence of ions. Hydrocolloids are generally
applied in food ingredients to control their rheology and structure [2]. The most common
hydrocolloid polysaccharides used in the food industry are gum, alginate, carboxymethyl
cellulose. Another hydrocolloid material that is frequently used is gelatin, which is derived
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from protein. The awareness of a healthy diet led to high fiber and low-fat food devel-
opment, making hydrocolloid one of the fastest growing industries. Since it can be used
as fat replacers in food, with relatively low concentrations (<1%) [3], with this condition,
hydrocolloids become an ideal material for drug delivery.
The most commonly studied hydrocolloids as drugs vehicles are plant or seed gums.
Many gums have been used in drug delivery systems, such as gum arabic, gum karaya,
and gum tragacanth. These three gums have different characteristics; gum arabic can
be dissolved at a high concentration of up to 50% due to its branched structure and low
molecular weight. Gum karaya is the least soluble gum; it swells and produces a viscous
colloidal solution when dispersed in water; the swelling behavior is due to its acetyl group.
Gum tragacanth forms a viscous liquid when dissolved in water, and it is considered
acid-resistant gum [4] Besides being used in food formulation, gum can serve as coating
and adhesives for pharmaceutical applications [5].
Gum as a carbohydrate can be divided into two parts based on its chemical compo-
nents: galactomannan and non-galactomannan gum. Galactomannans are polysaccharides
consisting of mannose backbone linked to galactose as side chains. Galactomannan solubil-
ity in water is influenced by the degree of galactose substitution and mannose/galactose
(M/G) ratio [6]. Non-galactomannan gum has no compound of mannose; instead, it has
major compounds of rhamnose-arabinose-galactose or rhamnose-galactose linkage such as
gum karaya [7]. Gum can be easily functionalized with other natural polymers to enhance
their applications.
Most polysaccharides have an anionic or neutral charge by nature, but chitosan
has a positive charge due to its amino functional group. The combination of natural
polymer hydrocolloid, gum and chitosan are the general examples of most research studies
of polyelectrolyte complexes (PEC) as a pharmaceutical excipient [8]. Several studies
investigated the PEC for drug delivery [9,10]. PEC occurred when two opposite charge
polyelectrolyte mixed simultaneously in an aqueous solution. This phenomenon is also
known as the self-assembly process, which indicates an interaction between anion and
cation polyelectrolyte driven by the system’s entropy [11].
There are three steps in forming a PEC: (a) primary complex formation, (b) secondary
complex formation, and (c) intercomplex aggregation, illustrated in Figure 1. When cationic
and anionic polymers are mixed, they form a random bond. This step is called primary
complex formation. In addition, the rearrangement and correction of bonds will occur as
the secondary complex formation. It forms intercomplex fibrils, entangles, or networks [12].
Copolymer PEC consisted of polycation and polyanion, also known as complex coacer-
vate, widely utilized in the pharmaceutical industry due to its characteristics [13,14]. This
review discusses natural and semi-synthetic polyelectrolyte coacervate complex for the
case study of drug loading and release. Apart from that, the polysaccharide is biocom-
patible in the human body without any adverse effects in vivo, making them suitable as
a candidate in the drug delivery field. The focus in this review is limited to gum-related
copolymer polysaccharide PEC. The mechanism, structure, drug loading, release ability,
and cytotoxicity assay of gum PEC are investigated thoroughly in this review.
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Figure 1. Illustration on the formation of polyelectrolyte complex (adapted from [12]). 
2. The Mechanism of Gum as Hydrocolloid PEC 
Chitosan as a cationic polysaccharide is typically used since it has a positive charge 
at pH below 6.5, making it favorable to form PEC with other anionic polymers [15]. The 
positive and negative charged polymers interact spontaneously and create a colloidal sus-
pension [16]. The structure produced from the electrostatic attractions is influenced by the 
ratio of cationic and anionic functional groups, which determine the characteristics of 
PEC, whether it is soluble or insoluble [14]. If the molar ratio of ionic group polyelectro-
lytes is nonstoichiometric, the PEC is water-soluble [17]. Generally, most synthetic PEC 
exhibits equal ratio polyelectrolytes of one form micellar aggregates, which has the struc-
ture of ladder-like and the scrambled egg model, this type of PEC is insoluble in water 
[18–20]. Polycation is categorized into two types based on ion charges: pendant-type have 
charges in the side groups, and integral-type have charges in the chain backbone [21]. 
Integral polycations provide non-stoichiometry PEC with weak polyanion. In the condi-
tion of excess polyanion, there is an interaction of anion with the cation sites of the 
equimolar complex to create a soluble complex [21]. However, the solubility of PEC pro-
duced is also greatly influenced by the branching and the strength of polyelectrolyte, the 
ionic strength of the environment, and the mixing order of polyelectrolyte components 
[22,23]. Simultaneous mixing of components has a higher probability of yielding stoichi-
ometric PECs [23]. 
The formation of PECs is affected by pH and the ratio of polymers. Several studies 
investigating the effect of parameters of gum copolymer PEC are summarized in Table 1. 
As observed in Table 1, the most investigated cationic polymer for studying polyelectro-
lyte complex in the last ten years is chitosan. Based on the existing data, three parameters 
can be summed up to the affecting PEC produced in this study.
Figure 1. Illustration on the formation of polyelectrolyte complex (adapted from [12]).
2. The Mechanism of Gum as Hydrocolloid PEC
Chitosan as a cationic polysaccharide is typically used since it has a positive charge
at pH below 6.5, making it favorable to form PEC with other anionic polymers [15]. The
positive and negative charged polymers interact spontaneously and create a colloidal
suspension [16]. The structure produced from the electrostatic attractions is influenced by
the ratio of cationic and anionic functional groups, which determine the characteristics of
PEC, whether it is soluble or insoluble [14]. If the molar ratio of ionic group polyelectrolytes
is nonstoichiometric, the PEC is water-soluble [17]. Generally, most synthetic PEC exhibits
equal ratio polyelectrolytes of one form micellar aggregates, which has the structure of
ladder-like and the scrambled egg model, this type of PEC is insoluble in water [18–20].
Polycation is categorized into two types based on ion charges: pendant-type have charges
in the side groups, and integral-type h ve charges in the chain backbo e [21]. I tegral
polycations provide non-stoichiometry PEC with weak polyanion. I the conditi of
excess polyanion, there is an interactio of ani with the cation sites of the equimolar
complex to creat a soluble complex [21]. However, the solubility of PEC produced is
also great y influenced by th branching and the strength of polyelectrolyte, the ionic
strength of t e environment, and he mixing order of polyelectrolyt components [22,23].
Simultaneo s mixing of components has a higher probability of y elding stoichiometric
PECs [23].
t r ti f poly ers. t
l r r s rize i l .
in Table 1, the most investigated cationic polymer for studying polyelectrolyte
complex in the last ten y ars is chitosan. Based on the existing data, three parameters can
be summed up to the aff cting PEC produced in this study.
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Table 1. The parameters used in the preparation of gum-based PECs.
Natural Polymers Parameters
Anionic Cationic
Gellan gum (G) Chitosan (C) (% w/v) ratio G:C of (1.5, 1.75, 2):1, acid and alkaline condition [24]
Gum Arabic (A) Chitosan % weight ratio A:C = 7:3 [25]
Xanthan gum (X) Chitosan % weight ratio X:C = (2–10):0.5, spray dried and freeze dried [26]
Carboxymethylated cashew gum Chitosan pH 4, ionic strength 0.05, molar charge ratio n+/n−: 0.1 to 20 [27]
Gellan gum Acrylic ion exchange resin Weight ratio polyanion solution:acrylic ion exchange resin = 5:5, pH
5.5, 25 ◦C, 24 h [28]Xanthan gum
Gellan gum Chitosan (% w/v) ratio G:C = 1:2, pH Chitosan ~1.8, pH Gellan gum ~12 [29]
Gellan gum TiO2, ZnO, Ag nanoparticles (NP) (gram) weight ratio G:NP = 1:0.2, 1:0.4, and 1:0.6 [30]
Gum karaya (K) Chitosan (gram) Weight ratio K:C = 0.938:0.062 [31]
Methacrylated gellan gum (MeGG) Chitosan Ratio MeGG:C = 2:1, 1:1, and 1:2. pH MeGG 5.42 (−17 mV), pHChitosan 4.06 (+38 mV) [32]
Xanthan gum Chitosan % weight ratio X:C = 2:1, 1:1, and 0.5:1, 25
◦C, volume of each
polymers is 37.5 mL [33]
Xanthan gum Ozarelix (O) Mass ratio X:O = 1:6, each polymer was dissolved in pH 6 ofdeionized water [34]
Carboxymethyl gum kondagogu (CMGK) Chitosan (% w/v) ratio CMGK:C = 0.01:0.05 until 0.1:0.2 (statistical studies) [35]
Gum ghatti (GG) Chitosan (% w/v) ratio GG:C = 0.1:0.05 until 0.5:0.25 (statistical studies) [36]
Gum kondagogu (GKG) Chitosan Weight ratio GKG:C = 10:1 until 50:1, pH 1.2–6.0 [37]
Gum odina (GO) Chitosan Weight ratio GO:C = 4:1, 5:1, 6:1. pH 4.5 [38]
Xanthan gum Chitosan (% w/v) ratio X:C = 0.7:0.7 and 1.0:0.7 with pH Chitosan 4.5 and6.2 [39]
Alginate
Chitosan Weight ratio polyanion:C = 75:75 [40]
Xanthan gum
Xanthan gum Cationic guar gum (CGG) (% w/v) ratio X:CGG = (0.02–0.18): (0.18–0.02) [41]





% weight ratio C:A = 0.99:0.01, 0.98:0.02, 0.97:0.03, 0.95:0.05, 0.9:0.1,
0.8:0.2, 0.7:0.3 [42]
Pectin/Gum arabic (P/A) % weight ratio C:P/A * = 0.98:0.01, 0.96:0.02, 0.92:0.04, 0.84:0.08,0.78:0.11, 0.7:0.15 [42]
Xanthan gum Chitosan Ratio C:X = 3:1, 1:1, 1:3 [43]
Gum Arabic Gelatin (Gn) % weight ratio A:Gn = 2.5:2.5, pH 3.5–4.5 [44]
Carboxymethyl gum katira (CGK) Chitosan (% w/v) ratio CK:C = (0.1–0.4): (0.03–0.05) [45]
Gum Arabic Cationized gelatin (CGn) (% w/v) concentration of A or CGn = 0.1–1, (v/v) mixing ratio A:CGn= (1–4):(1–5) [46]
Gum Arabic Chitosan(Low and high molecular weight) Molar ratio C:A = 1:0, 1:0.25; 1:0.5, 1:0.75, 1:1 [47]
Sterculia striata rhamnogalacturonoglycan (RG) Chitosan (high and low molecular weight) Mixing charge ratio (n+/n−) = 0.1–10 [48]
Gellan gum Chitosan (% w/v) ratio G:C = 0.85:0.4, pH 5 acetate buffer solution, roomtemperature, 24 h [49]
Gum Arabic Chitosan Mass ratio C ‡:A = 5:1, 4:1, 3:1, 2:1, 1:1. pH solution 4.0, 4.5, 5.0, 5.5 [50]
Methacrylated gellan gum Chitosan (% w/v) ratio MeGG:C = 1:1, flow rate 50 mL/hour [51]
Borate modified Polyvinyl alcohol (PVA) Cationic guar gum The film PEC is combined with 0, 1, 4, 7, 10% wt. of goldnanoparticle-nanocellulose filler [52]
Xanthan gum
Chitosan
Ratio X:C = 1:1 and 2:1. pH 5.8 and 6.5 [53]
Xanthan gum + Polyethylene oxide (PEO) Ratio X:PEO:C = 2:0.1:2 and 2:1:2, pH 5.8 and 6.5 [53]
Gellan gum Chitosan % w/v ratio G:C = 0.04:0.85, pH 5.4, 80 ◦C, 20 min [54]
Gum Arabic N,O-carboxymethyl chitosan (NOCC) % w/v ratio A:NOCC = 3:1 to 7:1. Temperature 25 ◦C, pH 3, 8 h [55]
Gum ghatti
Chitosan
Mass ratio G:C = 10:5 and 15:5. With 100 mg of lactose or starch, talc
30 mg, and 10 mg of Mg-stearate [56]
Xanthan gum Mass ratio X:C = 10:5 and 15:5. With 100 mg of lactose, talc 30 mg, and10 mg of Mg-stearate [56]
Carboxymethyl gum katira (CGK) Chitosan (% w/v) ratio CGK:C = 0.5:0.5 [57]
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Table 1. Cont.
Natural Polymers Parameters
Gellan gum Chitosan Mass ratio G:C = 5:10, 6:12, 7:14 [58]
Tragacanth gum (T) Insulin (I) (% w/w) ratio T:I = (0.1, 0.5, 1): 0.02, pH of Tragacanth was adjusted to3.7, 4.3, 4.6 or 6 [59]
Xanthan gum Chitosan % weight ratio X:C = 1.5:1.5 [60]
Gellan gum Cationic guar gum Mixing ratios G:CGG = 10:90 until 90:10, pH 3.72, 5.5, and 7.13 [61]
Okra gum (O) Chitosan Ratio O:C = 10:90 until 90:10, pH 5.0 [62]
Xanthan gum Chitosan (% w/v) ratio X:C = 0.5:0.5 [63]
Gellan gum Chitosan Ratio G:C = 10:90 until 65:35, 60
◦C, pH Chitosan and Gellan are 1 and
6, respectively [64]
Gum Arabic Chitosan Mass ratio C:A = 2:1, 3:1, 5:1, 10:1 [65]
Pectin Brea gum (B) Ratio B:P = 1:1, pH Brea gum 2.75 [66]
Gellan gum
Gelatin Polysaccharide added 1.5% of the dry content modified gelatin [67]
Xanthan gum
Mesquite gum (M) Chitosan Mixing ratio M:C = 7:1, 8.5:1, 10:1, 12:1. pH 4.5 [68]
Gum Arabic Fish gelatin % (g of A/100 g of Gn) = 0, 15, 25, 35. 150 rpm, 15 min, 25 ◦C [69]
Sterculia striata gum (CHG) Chitosan (w/w) ratio C:CHG = 4:1, n+/n− = 10 [70]
Gellan gum Chitosan (% w/w) ratio C:G = 80:20 and 60:40. 60
◦C, Gellan gum solution was
dropped into the Chitosan solution, pH 6 [71]
Xanthan gum Chitosan (% w/v) ratio C:X = 0.65:0.65. pH Chitosan 3.6, 4.6, and 5.6 (by HCland CH3COOH), mixing ratio C:X = 1:1 [72]
Xanthan gum Chitosan/Hydroxyapatite nanoparticle (NHA) Weight ratio X:C:NHA = 30:30:40, 25:25:50, and 20:20:60 [73]
Arabinogalactans gum acacia (GA)
Zein
Final volume ratio polysaccharide:Zein = 1:1 (concentration of each
polymers is 1 mg/mL), two methods were used: nanoprecipitation (n)
and desolvation (d) [74]
Acacia mearnsii gum (GN)
Glucuromannans gum ghatti (GGG)
Vochysia thyrsoidea gum (VT)
* The % weight ratio P/A was taken noted based on each of pectin and gum arabic. For example, the ratio P/A is 0.11, which means the mass of pectin is 0.11 and gum Arabic is 0.11, respectively. ‡ Mass ratio of
chitosan is the sum of the mass combination of gallic acid and chitosan.
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2.1. The Ratio of Polyanion and Polycation
2.1.1. Particle Size
The charge ratio of chitosan and gum show interesting results on the particle size
distribution of PEC. n+/n− between chitosan and carboxymethylated gum cashew (CMGC)
has relation with the concentration of CMGC, increasing the gum concentration overall
charge ratio produces larger particle size for the degree of substitution CMCG 0.16 and
0.36 [27]. The effect of charge ratio is more significant on the molecular weight of chitosan,
higher n+/n− have larger particle size for the combination of low (7.8 × 104 g mol−1) and
high molecular weight chitosan (4.6 × 105 g mol−1) with Sterculia striata rhamnogalactur-
onoglycan. However, low molecular weight chitosan produces a bigger particle size than
the high molecular weight [48]. The effect of the weight ratio of carboxymethyl gum kond-
agogu (CMGK) to chitosan was more significant than that of chitosan to CMGK. A higher
ratio of CMGK to chitosan produced a bigger particle size than the higher ratio of chitosan
to CMGK [35]. A similar trend was also observed for PEC made of gum ghatti/Pluronic F-
127/chitosan. The combination of Pluronic was quite prominent for the growth of particles,
but it can be attenuated at a higher concentration of gum ghatti in the system [36]. The size
of polyelectrolyte nanoparticles synthesized from carboxymethyl gum katira (CK)-chitosan
was more influenced by the concentration of CK than chitosan [45]. The increased gellan
gum concentration to chitosan with the same weight ratio of 1:2 produced a larger particle
size for the entrapment of Tamoxifen citrate [58].
In contrast, gum Arabic has opposite results on the particle size with the increasing
concentration. Tsai and co-authors analyzed the combination of chitosan, pectin, and
gum Arabic PEC; the result is that increasing the concentration of gum Arabic in chitosan
solution reduces the particle size significantly. Meanwhile, the combination of pectin +
gum Arabic combined in chitosan solution showed an uneven particle size distribution
with the rising polysaccharide concentration [42]. Sarika and co-workers who investigated
the cationized gelatin/gum Arabic PEC also stated that a higher volume ratio of gum
Arabic produced a clear PEC and smaller particle size ranging from 60 to 170 nm [46].
Hu et al. (2016) studied the formation of PEC from gallic acid-chitosan conjugate and gum
Arabic; a higher ratio of gum Arabic produced smaller particle size, which is similar to the
results of Tsai and co-authors [50]. With these results, the effect on particle size depends
on the type of gums. Gum Arabic has the opposite behavior to the other gums since it
has different chemical compositions. Several researchers mentioned that the more viscous
gum produces a larger particle size; this also correlates with the chain flexibility of the gum
itself [36,45,48].
For drug delivery applications, some studies have shown that the particle size of
drug-loaded particles is more affected by the polymer ratio than the drug concentration.
Narkar et al. investigated the effect of chitosan-coated amoxicillin gellan beads, raising
the gellan gum concentration with the same antibiotic and chitosan concentration gave
a slightly bigger diameter of particle size, 0.86 ± 0.6 mm and 0.91 ± 0.7 mm for 1.5%
and 1.75% w/v gellan solution, respectively [24]. In the preparation of PEC chitosome,
the drying method has a significant impact on the particle size. Higher ratio (% w/w) of
xanthan gum to chitosan resulted in larger particle size of chitosome for ratio 1:1 and 2:1;
this is valid for 60 mg/mL [33]. The results are interesting since the size of the 60 mg/mL
liposome size is smaller (195 ± 59 nm) than the 30 mg/mL (247 ± 97 nm). Another study
performed by Manconi et al. [26] showed that the weight ratio of xanthan gum and chitosan
2:0.5 has a bigger size of chitosomes than the ratio of 8:0.5; however, this is influenced by
the different drying methods of chitosomes [26]. The chitosomes produced at a ratio of
xanthan gum and chitosan of 2:0.5 were dried using freeze-dry, while the ratio of 8:0.5 was
spray dried.
2.1.2. Mechanical Properties
Besides particle size, the ratio of biopolymer in PEC also plays a crucial role in the
mechanical properties of PEC. Several studies show that gum in the natural cationic
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polymer affects the rheological structure, such as storage modulus (G′), loss modulus (G”),
and tensile strength. Chitosan membrane has better tensile stress and elongation capability
than gum Arabic or pectin membrane that were too fragile to be measured. The addition
of gum Arabic in the chitosan membrane improved the tensile strength of than pectin–
chitosan membrane. However, gum Arabic did not improve the elongation properties
of the chitosan membrane [25]. The study by Tsai et al. (2014) using the combination of
pectin/gum Arabic/chitosan gave similar results; the best tensile strength was obtained
at the ratio of C:P/A at 0.84:0.8. However, the higher pectin/gum Arabic ratio did not
change the tensile strength [42]. The high molecular weight of chitosan (HMWC) has
better puncture strength than the lower one (LMWC). A small ratio of gum Arabic in
high molecular weight chitosan film (0.25:1 and 0.5:1) significantly decreased the puncture
strength of pure chitosan film. Higher ratio gum Arabic-HMWC (0.75:1 and 1:1) showed
better mechanical properties than the native HMWC film. The addition of gum Arabic
does not improve the elongation of gum Arabic-chitosan film [47].
Spray-dried chitosomes with a low ratio of xanthan gum to chitosan (2:0.5 % w/w)
have a predominance of viscous over elastic properties. Freeze-dried chitosome has higher
G′ than G” with all ratio xanthan and chitosan, however increasing xanthan concentration
cause decreasing value of G′ and G”. With the increasing concentration (2–10% w/w), pure
xanthan gum solution showed higher G′ than G”; this behavior shows the reinforcement of
chitosan and xanthan in the PEC network formation depend on the drying methods [26]. A
similar trend of spray-dried xanthan gum/chitosan with a mixture of liposomes was also
exhibited by Manca et al. (2012); G′ was always higher than G” at all ratios of chitosan to
xanthan gum [33].
The prevalence of elastic over viscous material is advantageous for developing a mu-
coadhesive system since more elastic properties indicate stronger interaction between the
PEC and the biological matrix [26,33]. Kim and co-authors investigate the gel formulation
of chitosan–xanthan gum with concentration 6% and 9% gel, the shear stress for 6% gel for
all ratio chitosan and xanthan developed in orderly profile, which at low shear rate means
low shear stress [53]. However, the 9% gel showed a disorder shear stress profile at certain
chitosan and xanthan gum PEC parameters. The rheological property is greatly affected by
the composition ratio of biopolymer; the whole parameters of gel indicate shear-thinning
behavior. Magnetic xanthan gum and chitosan hydrogel (MPECH) showed better G′ and
G” than the original PEC hydrogel (PECH), the value of G′ is always higher than G” [60].
The addition of magnetic nanoparticles to PECH improves the compressive strength of the
original PECH at a strain rate of 90%, MPECH and PECH have a stress value of 0.042 and
0.037, respectively.
The different types of acids used for pH adjustment also influence the rheological
behavior; Ćirić et al. (2020) show that the chitosan/xanthan gum PEC that adjusted with
acetic acid has +a higher hysteresis area than hydrochloric acid [72]. This phenomenon
indicates that chitosan possesses the best interactions with xanthan gum in the acetic acid
solution at pH 3.6. Combining xanthan gum/chitosan and hydroxyapatite nanoparticles
has the best compressive strength and modulus at ratio 25:25:50 for X:C:NHA, decreasing
polysaccharide content in the PEC while increasing NHA would make insufficient binding
excess NHA [73].
Increasing the ratio of gum Arabic to NOCC at 7:1 reduced the G′ and G” values, and
the viscoelastic properties depended on the frequency, which can be said to follow the
viscoelastic nature of gum Arabic solution [55]. Meanwhile, increasing gum concentration
in the Chitosan-Gum Odina complex resulted in a higher loss in modulus than storage
modulus [38], the highest mechanical strength for the ratio of gum Odina and Chitosan
was 5:1, which produced the highest G” and G′ at low strain percentage (0.1–2%). The
addition of acid-resistant materials (cellulose acetate phthalate) in the gelatin film caused a
significant drop in the viscosity and shear stress, which risk the ability of gelatin to form
the film. A small amount of gellan gum and xanthan gum could increase the viscosity
and shear stress of gelatin-acid resistant mixture [67]. No significant change of G′ and G”
Processes 2021, 9, 1796 9 of 29
was observed for the increasing mixing ratio of mesquite gum and chitosan insoluble PEC,
the loss modulus was always higher than the storage modulus [68] which is similar to the
study of gum Arabic and NOCC insoluble PECs. Higher ratio of gellan gum (40:60) in the
chitosan–gellan gum hydrogel show three times higher elastic modulus than the ratio of
gellan gum to chitosan 80:20 [71].
2.2. pH
The mechanism of PEC formation is based on the electrostatic interaction of two
oppositely charged polymers. Hence, it is necessary to understand the charge characteristic
of material at a specific pH range. Potentiometric titration can be conducted to know the
effect of pH on the polymer state. Da Silva et al. (2015) show that gum Arabic has two
pH-dependent species: uronic acid and amino acid (gum residue). Gelatin has an amino
acid group that is also pH-dependent; both polymers indicated that the pH of 2–4 has a
more pronounced contribution to the overall titration curve. The uronic acid of commercial
gum Arabic, which has a pKa value of around 3.61, has the optimum interaction with
gelatin at pH 4 [44]. Chitosan and gum Odina PEC have an equivalent stoichiometric
charge ratio of both polysaccharides with the ratio of O: C at 5:1 [38]. Circumstantially, the
ratio of the polymer affects the potentiometric titration. This phenomenon can be correlated
to the higher mass in the solution, which means more ionic linkage is needed to neutralize
the functional group ion. Lankalapalli and Kolapalli (2012) also investigated the association
between mixing ratio and pH in the formation PECs of gum karaya and chitosan; less ratio
of gum karaya in the chitosan solutions means lower pH and higher conductivity [31].
2.2.1. Zeta Potential
Comprehending single natural polymer pH characteristics needs to be considered one
of the most critical roles in the complex formation of polyelectrolyte. The zeta potential
versus pH analysis must be carried out to locate the isoelectric point (pI) with no potential
charge at a specific pH value. Sarika and co-authors (2015) investigated the effect of pH
on cationized gelatin/gum Arabic complex with mixing ratio 1:1 (v/v) with each polymer
concentration 0.1% w/v; it can be seen at low pH (<4) the cationized gelatin (CGn) and
gum Arabic (A) have a positive and negative charge, respectively. The appearance of
the CGn/A complex depended on pH; the zeta potential of PEC changed significantly,
unlike the natural polymer mixtures. The turbidity of PEC showed a drastic increase up to
pH 6.6, which is attributed to the strong electrostatic interactions between amino groups
on CGn and carboxylate groups on A [46]. The zeta potential of HMWC is higher than
LMWC at pH 4, and the combination of A and HMWC at different molar ratios showed
higher potential than LMWC/A at pH 4–5.5. The turbidity of chitosan and gum Arabic
was more prominent at pH 5.5 than pH 4 and 5 due to high solubility and high degree
ionization of gum at higher pH (~7) [47]. This result is similar to the study of chitosan
and gum Arabic PEC by Hu and co-authors (2016); higher pH produced more turbid PEC
and smaller zeta potential. The optimum pH of interaction gum Arabic and chitosan to
form PEC was five since it yields the highest count rate, small particle size, and most
homogeneous distribution [50]. The molar charge ratio of HMWC or LMWC with Sterculia
striata rhamnogalacturonoglycan (RG) on zeta potential is more favorable toward the
high charge ratio of LMWC and RG than the mixture of HMWC/RG. This result indicates
that HMWC has better interaction with the polyanion RG than LMWC, confirmed by the
more significant charge compensation due to higher consumption of amino groups on
HMWC [48].
Knowing the zeta potential of the material is advantageous to understand the mech-
anism of PEC further. Zeta potential is more dependent on pH than the mixing ratio of
natural polymer. For the case of cationic guar gum (CGG) and gellan gum (G), different
pH with the same mixing ratio (CGG: G = 70:30) yield significantly different zeta potential.
Kaur and Kaur (2018) mentioned that pH 5.5 show the lowest zeta potential value, which
indicates the maximum favorable interaction between CGG and G; the species distribution
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profile of CGG also supports this with >90% in protonated hydroxyl group H3O+ and G
with >90% in deprotonated carboxylate ions COO-. The highest turbidity and lowest trans-
mittance were demonstrated at pH 5.5 indicated nonstoichiometric insoluble complexes of
CGG and G [61]. This result is also very similar to the study by Nur and co-author (2018),
who chose pH 4.6 and ratio 0.02:0.5 (I:T) as the best condition for insulin (I) and tragacanth
gum (T) PEC, which also exhibited the highest zeta potential value (−7.5 mV) compared to
other pH and ratio [59]. The selection of pH is based on the pI insulin around 5.5–6.4; below
the pI value, insulin is positively charged. This result coincides with the potential value
of tragacanth gum to be negatively charged at pH 4.6. Unlike the study of brea gum and
pectin, both do not have an opposite charge at the same pH. Brea gum has a positive charge
below pH 3.7, while pectin negatively charges its natural solution. Therefore, to prepare
hydrogel PEC from both materials, the authors mix each solution at a separated pH of 2.75
and unadjusted pH conditions for brea gum and pectin, respectively [66]. The strength
of the electrostatic interaction (SEI) also can be calculated to know the optimum pH of
the interaction among the two opposite charged polymers. For instance, Rodríguez et al.
determined the SEI value between mesquite gum and chitosan which is also correlated
with the zeta potential for each natural polymer [68].
2.2.2. Swelling Behavior
pH is an essential parameter in the swelling studies of PEC. This parameter correlates
to the mechanical properties of the material with the effect of ions in the solution. The
investigation of swelling studies is necessary to understand whether the PEC is suitable
for oral route drug delivery. The Human GI tract is differentiated into three different pH,
the stomach has a pH range around 1.2–2.2, the duodenum has a value of 5.8, and the
jejunum has a pH of 6.8. Argin and co-authors prepared xanthan–chitosan hydrogels to
deliver probiotics to the intestines [39]. The xanthan–chitosan PEC hydrogels were tested
in simulated gastric fluid (SGF) and simulated intestinal fluid (SIF) with pH 2 and pH 6.2,
respectively. It was observed that xanthan (X)-chitosan (C) hydrogel is pH-responsive; it
did not swell in SGF and rapidly swell for the first 2 h in SIF. Higher xanthan ratio (1%)
swell faster than the low content of xanthan (0.7%), the best swelling resulted in ratio X:C
of 1:1.
Other studies by Li et al. indicated the same 1:1 ratio of chitosan–xanthan gum film
matrix showed constant swelling at pH 1.2 (SGF) for 2 h and slightly swollen at pH 6.8 (SIF)
for the next 22 h. While the film erosion indicated a slightly reduced of the remaining mass
in SGF, and subsequently in SIF, this indicated the stable complex formation of PEC in the
simultaneous immersion on SGF and SIF [40]. Shao and co-authors (2015) have a similar
swelling profile behavior of drug-loaded X-C matrix tablet; however, the erosion behavior
is different with Li et al. since they also take account of the amount of drug release at time
t [43]. These authors used high molecular weight chitosan: 370 kDa and 400 kDa with
degree acetylation of 85–86.5%.
For chitosome made of chitosan and xanthan with two different drying methods
(freeze-dried and spray dried), freeze-dried chitosome has a higher swelling ratio than
spray dried. However, the freeze-dried chitosome has the highest swelling ratio after
more than 5 h of immersion in SGF compared to the SIF medium, while the spray-dried
chitosome did not show any appreciable differences [26]. Chitosan-coated amoxicillin
gellan beads have a higher swelling ratio at pH 7.4 than pH 1.2 due to deprotonation amino
groups of chitosan and the predominate swelling effect of gellan in alkaline conditions [24].
Chitosome has a different swelling profile than the other previously mentioned xan-
than gum-chitosan PEC can be caused by a higher ratio of xanthan in the chitosome
(X:C = 2:0.5) and the inclusion of liposomes in the preparation. Gum kondagogu (GKG)
and chitosan hydrogel have pH-dependent swelling; low pH 1.2 showed high swelling
index compared to more alkaline pH conditions (pH 5, 6.8, 8). This result is similar to the
previous chitosome; the GKG-C hydrogel is synthesized with a high gum ratio. Kim et al.
investigated the swelling effect on two different pH of preparation X-C PEC (pH 5.8 and
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6.5); it was observed that pH 6.5 X-C PEC has a higher swelling ratio than pH 5.8 PEC. The
swelling study was conducted in distilled water for 4 h, which showed a prominent effect
of pH in the preparation method on the swelling behavior.
2.3. Mixing Order
The mixing sequence between the cationic and anionic natural polymers affected the
PEC properties (particle size, tensile strength, and stability). Few studies were conducted
to understand further the effect of mixing order in the PEC, but clearly, it significantly
influenced the resulting PEC. Silva et al. (2010) explored mixing order as a function of
CMCG degree substitution (DS); when chitosan was added to CMCG 0.36, the composite
has a larger particle size than CMCG 0.36 was added to chitosan [27]. This result is similar
to CMCG 0.16, but it produced a smaller particle size than the CMCG 0.36. Amin and
co-authors did an interesting study of mixing order between chitosan (C) and gellan gum
(GG). They investigated the sequence of PEC film preparation on the mechanical properties.
The addition of GG to C improved Young’s modulus and tensile strength by 1.7 and 2.7
times, respectively. While C was added to GG, it produced particles with better toughness
(3.6 fold) than GG into C. Both mixing orders show little difference in their water vapor
transmission rates [29].
The influence of the molecular weight of chitosan and the charge ratio was studied
towards the mixing order between chitosan and RG. High MW C/RG produced a larger
particle size than high RG/C at a charge ratio of 0.8. Fluctuate particle size profile was
observed at a high charge ratio of 4 to 10. On the contrary, low MW C/RG or RG/low MW
C has a similar particle size in low charge ratio (0.2–0.8); it has a larger particle size for low
MW C/RG in charge ratio of 6–10 than RG/low MW C. The stability of PEC particle size
was good (up to 30 days) for low MW C despite the mixing order at a charge ratio of 0.1
and 5 [48].
A recent study by da Silva and co-authors (2020) has proven that mixing order was
influential in the resulting PEC. The authors studied the PEC preparation from zein and
several polysaccharides. There are two terms used by da Silva et al. to investigate the
mixing order of PEC. If zein were added to the polysaccharide, it would be described
as nanoprecipitation. For the opposite case (polysaccharide to zein), it will be called
desolvation. Based on their results, we can understand that the mixing order significantly
affects particle size. On the zein control sample of desolvation and nanoprecipitation, the
particle size of the desolvation method is 3.4 times smaller than the nanoprecipitation
method. However, the most intriguing result of mixing order against all polysaccharides is
smaller for nanoprecipitation of zein to polysaccharide solution. This result explains that
zein diffusion was relatively easier due to its lower molar mass; the polysaccharide could
accommodate zein to stabilize the formed particle [74].
3. Gum-Based PECs for Biomedical Applications
Natural gums are composed of heterogenous monosaccharides, including glucose,
galactose, rhamnose, arabinose, xylose, mannose, uronic acids that construct three-
dimensional interconnected molecular networks. The structure majorly modulates the
intensity of the gels’ coordination and gum composition in accompanies with the ionic
strength, pH, and temperature [75]. As a biopolymer, natural gums present outstanding
biocompatibility/cytocompatibility, biodegradability, and water solubility. The rule out the
possibility of human body rejection makes the natural gums a priority in tissue engineering
applications. Moreover, most gums are secure to be consumed, which can easily proceed
towards the drug delivery field [76]. Compared to synthetic polymers, the availability,
lower toxicity, and best-economic aspect become the critical value of natural gums [77].
Nevertheless, these advantages are accompanied by several drawbacks: thickening
effect, high swelling, pH-dependent solubility, susceptibility of microbial contamination,
and the complexity of viscosity adjustment due to relatively rapid biodegradation [75].
Therefore, chemical modification is required for improving their features in biomedical
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applications. Based on the natural gums chemical structure, the existence of acetic, pyruvic,
carboxyl groups residual side chains make several types of NG as negatively charge biopoly-
mers that create the possibility of incorporating oppositely charged biopolymers such as
chitosan and cationic modified non-ionic gum and synthetic polymer (e.g., acrylic ion
exchange resin and polyvinyl alcohol, Polyethylene oxide)). As the most common natural
polycationic, chitosan presents positively charged amino groups that form polyelectrolytes
complexes towards anionic groups of NG through electrostatic interaction, dipole-dipole
interaction, and hydrogen bonding [78]. A summary of Gum-based PECs with various
polycationic modified and their biomedical application are briefly summarized in Table 2.
Table 2. Gum-based PECs for biomedical application for: (A) Tissue and bone regeneration; and (B) Cargo delivery.
A Tissue and Bone Regeneration
Gum-Based PECs Composite Carrier Form Application
Methacrylate Gellan
Gum-Chitosan/Arginylglycylaspartic acid Hydrogel Fibers Tissue engineering [51]
Xanthan Gum-Chitosan@ Magnetic Fe3O4 Hydrogel Scaffolds Tissue engineering [60]
Gellan Gum-Chitosan Hydrogel Scaffolds Tissue engineering [64]
Xanthan Gum-Chitosan/Hydroxyapatite Scaffolds Bone-Regeneration [73]
B Cargo Delivery
Gum-Based PECs








t~18% = 24 h (Simulated Gastric
Fluid (SGF; pH 2; T = 37 ◦C)
t~39% = 24 h (Simulated
Intestinal Fluid (SIF); pH 6,8;




t~48% = 24 h (Simulated Gastric
Fluid (SGF; pH 2; T = 37 ◦C)
t~68 = 24 h (Simulated
Intestinal Fluid (SIF); pH 6,8;
T = 37 ◦C)
Gellan Gum-Chitosan Amoxicillintrihydrate Hydrogel Beads
Gastrointestinal
Delivery [24]
t~83% = 24 h (0.1 M HCl; pH




(DS) Tablets Oral Delivery [31]
t92,94% = 24 h (Phosphate
Buffer; pH 7.4; T = 37 ◦C)
carboxymethyl gum
kondagogu-chitosan Ofloxacin (OX) Nanoparticles -
t50% = 24 h (Phosphate Buffer;
pH 7.4; T = 37 ◦C) [35]
Gum Ghatti–Chitosan@
Pluronic F-127 Ofloxacin Nanoparticles
Drug Delivery and
Antibiotic activity [36]
t32% = 12 h
(Phosphate Buffer; pH
7.4; T = 37 ◦C)
Gum Odina-Chitosan - Microspheres Colon-specificdelivery [38] -





tnegligible = 2 h (Simulated
Gastric Fluid (SGF; pH 2;
T = 37 ◦C)
t100% = 5 h (Simulated
Intestinal Fluid (SIF); pH 6,8;
T = 37 ◦C)
Cationic guar
gum-Xanthan Gum Diclofenac Sodium Microspheres
Gastrointestinal
Delivery [41]
t61.02% = 12 h
(Phosphate Buffer; pH
7.4; T = 37 ◦C)
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Table 2. Cont.
B Cargo delivery
Gum-Based PECs Composite Carrier Form Application
Xanthan gum-Chitosan Theophylline (Th)
Tablets Oral Delivery [40]
t~28% = 2 h; t~99.8% = 24 h;
(Simulated Gastric Fluid (SGF)
for 2 h followed with
Simulated Intestinal fluid (SIF)
for 22 h; pH 1,2 and 7.4
respectively; T = 37 ◦C)
Metoprolol
succinate (MS)
t~37% = 2 h; t~92% = 24 h;
(Simulated Gastric Fluid (SGF)
for 2 h followed with
Simulated Intestinal fluid (SIF)
for 22 h; pH 1,2 and 7.4
respectively; T = 37 ◦C)
Alginate-Chitosan Theophylline (Th)
t~18% = 2 h; t~84% = 24 h;
(Simulated Gastric Fluid (SGF)
for 2 h followed with
Simulated Intestinal fluid (SIF)
for 22 h; pH 1,2 and 7.4
respectively; T = 37 ◦C)
Metoprolol
succinate (MS)
t~37% = 2 h; t~96% = 24 h;
(Simulated Gastric Fluid (SGF)
for 2 h followed with
Simulated Intestinal fluid (SIF)
for 22 h; pH 1,2 and 7.4
respectively; T = 37 ◦C)
carboxymethyl gum
katira-Chitosan Ofloxacin Nanoparticles Ophthalmic delivery [45]
t~92% = 24 h (0.1 M HCl; pH







Tablets Oral Delivery [43]
t4.8% = 1 h; t95% = 24 h
(Simulated Gastric Fluid (SGF)
for 1 h followed with
Phosphate Buffer for 23 h; pH
1,2 and 6.8 respectively;










t~60% = 10 h; t100% = 12 days
(Phosphate Buffer; pH 7.4;






t~40% = 24 h; t100% = 12 days
(Phosphate Buffer; pH 7.4;
T = 25 ◦C)
Gellan Gum-Chitosan OndansetronHydrochloride Solid Dosage Nasal delivery [49]
t99% = 8 h (Phosphate Buffer;
pH 7.4; T = 37 ◦C)
Gellan Gum-Chitosan Curcumin Nanogel Intra-tumoral [54]
t~94% = 20 h
(Phosphate Buffer; pH 7.4;




Hydrogel Topical Delivery [53]
t~1772 (µg/mL) = 168 h
(Phosphate Buffer; pH 7.4;




t~1103 (µg/mL) = 168 h
(Phosphate Buffer; pH 7.4;
T = 37 ◦C)
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Table 2. Cont.
B Cargo delivery





t54.93% = 6 h (0.1 M HCl; pH
1,2; T = 37 ◦C)
Xanthan Gum
(XG)-Chitosan
t62.27% = 6 h (0.1 M HCl; pH
1,2; T = 37 ◦C)
Gellan Gum-Chitosan Tamoxifen citrate Nano capsules Intra-tumoral [58] t77.16% = 8 h (Phosphate Buffer;pH 7.4; T = 37 ◦C)
carboxymethyl gum
katira-Chitosan Ofloxacin Nanoparticles
t~45% = 2 h; t84.32% = 24 h (0.1
M HCl for 2 h followed with
Phosphate Buffer for 22 h; pH
1,2 and 7.4 respectively;
T = 37 ◦C) [57]
Xanthan Gum
(XG)-Chitosan Indometachin Membranes Topical Delivery [63]
t20 (mg drug/mg carrier) = 6 h
(Phosphate Buffer; pH 7.4;
T = 37 ◦C; 0.092 mm thickness)
Pectin-Chitosan
Tenofovir Tablets Vaginal Delivery [79]
t~98% = 75 h (Simulated
Vaginal Fluid (SVF; pH 4.2;
T = 37 ◦C)
Locust Beam
Gum-Chitosan
t~93% = 75 h (Simulated
Vaginal Fluid (SVF; pH 4.2;
T = 37 ◦C)
Xanthan gum-Chitosan
(Prepare in Hydrochloric
acid (HCl) solution (pH
5.6)
Ibuprofen Solid Dosage Oral Delivery [72]
t48% = 10 h (PEC: drug
ratio = 1:1)
t50.67% = 10 h(PEC: drug
ratio = 1:2) (Phosphate Buffer;
pH 7.2; T = 37 ◦C)
Xanthan gum-Chitosan
(Prepare in Acetic Acid
(AA) (pH 5.6)
t56.84% = 10 h (PEC: drug
ratio = 1:1)
t67.75% = 10 h
(PEC: drug ratio = 1:2)
(Phosphate Buffer; pH 7.2;
T = 37 ◦C)
3.1. Gum-Based PECs for Tissue and Bone Regeneration
The current development of gum-based PECs as tissue engineering leads to the ad-
vancement of scaffolds materials. To date, the foremost challenge of tissue engineering
development is that the material should be mechanical and functional mimicry of tissue
framework [80]. Sant et al. (2017) have fabricated scaffold containing methacrylate modi-
fied Gellan Gum (MeGG) and Chitosan with 1:1 ratio with addition of Arginylglycylaspartic
acid (RGD) modification through self-assembly microfluidic approach and photocrosslink-
ing technique [51]. The aligned fibrous in their study have successfully replicated the
hierarchical structure of natural collagen fibers. These formed fibrous materials present
an excellent environment for cells encapsulation, such as rat fibroblasts, cardiomyocytes,
and human mesenchymal stem (hMSCs) with insignificant effect in viability under mild
conditions. The RGD also acts as scaffold binding sites for cell adhesion and proliferation
of hMSCs. This study also presents the possibility of photocrosslinkable MeGG tuning the
physicochemical and mechanical characteristics for broad application of tissue engineering
such as bone, skeletal, and cardiac muscle to neural tissue.
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In line with the previous study, other characteristics such as the rate of material
disintegration, porosity, interconnecting pore framework, and structural homogeneity
also play essential roles in regulating the suitability of scaffold for supporting cell growth.
de Oliveira and co-authors (2019) reported the composition of GG/chitosan crucially
regulating the hydrophilicity-hydrophobicity and mechanical strength of the material,
which further beneficially improves bone interaction mesenchymal stem and GG/CS
PECs [64]. Moreover, the optimal ratio of CS/GG (80:20) and CS/GG (60:40) present
structural homogeneity and high porosity (ranged from 100–200 µm), which present as
one of the desired features since they can imitate the extracellular matrix framework
and functions including acted as support cell migration and proliferation, metabolites
transportation and assembly and deposition new ECM substances [64].
Natural gums and nanomaterials (such as Fe3O4 magnetic nanoparticles (MNPs and
Hydroxyapatite (HAPs)) present merits features with addictive characteristics. As reported
by Rao and co-authors reported that the hydrophilic properties of Xanthan Gum-Chitosan
PECs and the external magnetic field of MNPs create scaffolds with stimulating cellular
interaction [60]. The merits properties can enhance the cell adhesion and proliferation of
NIH3T3 fibroblasts and refined properties such as rheological and compressive features.
Low tensile strength and loading bearing are the main issues for implementing synthetic
hydroxyapatite (HAP) implants [81]. Recent advances in nanotechnology have made
the fabrication composite of HAP and polyelectrolytes (natural gums and polycations
material) possible. The composite possesses biocompatibility improvement and bone
integration capability, including osteoinductive and osteoconductive. For instance, Zia et al.
(2020) designed a tri-scaffold based on Xanthan Gum-Chitosan composite incorporating
HAPs [73]. The utilization of this gum has involved the refinement of physical, mechanical,
and biological features of the fabricated scaffold. The synergistic effect of its substances
presents higher matrix stiffness, more significant interconnectivity pores, smaller crystallite
size, and additional carboxylate groups from XAN, which provide high surface area and
favors osteoinduction and protein adsorption. Moreover, the integrated scaffold exhibits
a moderate degradation rate and antibacterial properties. In addition, the tri scaffold
composite also stimulates the differentiation of MG-63 cells with bone cells which potential
of improving the rate and ability of bone regeneration [73].
3.2. Gum-Based PECs for Drug Delivery
Gum-based PECs have been developed for various dosage forms, including tablets,
gel beads, micro- and nanoparticles, membrane film, and hydrogel, having physiologically
responsive carriers due to the swelling ability. The combination of gum and polycation
may respond towards physiological environment either by the interaction towards tissue
surface (mucoadhesive character) or by modifying the mechanical characteristic (swelling
characteristic) through physiological fluid contact (e.g., gastrointestinal tract (GIT), nasal,
vaginal, lacrimal, etc.) which effectively modulate the release of the drug. Many mod-
ified release formulations have been developed to improve drugs’ bioavailability, such
as delayed-release, sustained release, site-specific release, and receptor-targeted [82]. In
common, controlled drug release was found in the peroral dosage form formulation of
gum-based PECs to hinder the mucosal irritation and safeguarding drug throughout the
stomach from low pH release and enzyme degradation as well as maintain delivery to-
wards the specific site (refer to Table 2) [83]. Another common system, sustained drug
release efficiency, delivered optimum drug concentration for prolonged-release time to
preserve therapeutic drug concentration at the specific site and circumvent therapeutic
substances’ toxicity and side effects. Several types of gum-based PECs were developed for
sustained drug release, several administration routes (depicted in Figure 2) will be covered
and defined in the following sections.
Processes 2021, 9, 1796 16 of 29Processes 2021, 9, x FOR PEER REVIEW 




Figure 2. Drug administration route. 
3.2.1. Gum-Based PECs for Peroral Delivery 
Gum-based PECs have been widely developed for the diverse oral delivery formula-
tion, commonly for active pharmaceutical ingredients conveyance towards specific sites 
of the gastrointestinal system. Despite their biodegradability and nontoxicity, their main 
characteristics (swelling ability, mucoadhesive, and pH sensitivity) play a significant role 
in oral delivery: however, their suitability for oral delivery also depends on the residence 
time in the gastrointestinal (GI) tract and drug solubility and permeability. The gum-
based PECs are acknowledged for their suitability for oral delivery because of the strong 
interaction between anionic gum (e.g., Xanthan Gum, Pectin, Alginate, Gellan Gum, Trag-
acanth Gum, and Gum Ghatti) and polycation (e.g., cationic guar gum and Chitosan) un-
der acidic pH which also suitable for intestinal and colon-specific delivery (refer to Table 
2). The presence of several enzymes can improve their biodegradability characteristic (e.g., 
galactomannanase, pectinolytic enzymes, microflora) [76,84–86]. Furthermore, bacteria 
combined with chitosan’s mucoadhesive characteristic perfectly matched colon-specific 
drug delivery [87]. Roy et al. (2013) evaluated that the presence of cell-associated enzymes 
of rat cecal and colonic enzymes effectively degrade the gum Odina-chitosan complexes. 
They also reported that the strong interaction and elastic mechanical strength modulated 
the biodegradability of gum-based PECs [38]. 
Most peroral studies only simulated the drug release based on the simulated gastric 
and intestinal fluid kinetic release. However, the peroral delivery is more complex in an-
imal or human systems which several factors have to be considered, such as fasting or fed 
condition, nature of the taken meal, sleep, posture of human corresponding to the density, 
Figure 2. Drug administration route.
3.2.1. Gum-Based PECs for Peroral Delivery
Gum-based PECs have been widely developed for the diverse oral delivery formula-
tion, commonly for active pharmaceutical ingredients conveyance towards specific sites
of the gastrointestinal system. Despite their biodegradability and nontoxicity, their main
characteristics (swelling ability, mucoadhesive, and pH sensitivity) play a significant role
in oral delivery: however, their suitability for oral delivery also depends on the residence
time in the gastrointestinal (GI) tract and drug solubility and permeability. The gum-based
PECs are acknowledged for their suitability for oral delivery because of the strong interac-
tion between anionic gum (e.g., Xanthan Gum, Pectin, Alginate, Gellan Gum, Tragacanth
Gum, and Gum hatti) and polycation (e.g., cationic guar gum and Chitosan) under
acidic pH which also suitable for intestinal and colon-specific delivery (refer to Table 2).
The presence of several enzymes can improve their biodegradability c aracteristic (e. .,
l t s , ti l ti s, i r fl r ) [ , ]. rt r r , t ri
i it it ’ i t i ti f tl t l - ifi
. l. (20 ) e l t t t r
l .
i testi al fluid kinetic release. How ver, the pe oral delivery is more complex in
animal or human systems which several factors have to be considered, such as fasting
or fed condi ion, nature of the taken meal, sle p, posture of human correspon i g to
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the density, size, and the resistance of dosage form. Therefore, the advanced study must
justify gum-based PECs on gastrointestinal delivery through ex vivo and in vivo studies.
For specific site delivery, such as intestinal and colon targeting, the mucoadhesive plays
a vital role in the drug delivery. Complexes interaction of gum-based PECs provides
extended time release of the drug; however, the mucoadhesive characteristic facilitates the
localization of drug release at specific sites and dwindles the local irritation.
Manconi et al. (2010) successfully created chitosan-xanthan gum with liposome coating
formulation by spray and freeze-drying followed by direct compression, generating tablets
for colon-targeted delivery [26]. As a validation, the ex vivo study was carried out on the
treated intestinal tissue (e.g., duodenum, jejunum, ileum, and colon) of 24-h fasted Wistar
rats (13-week-old) for a mucoadhesive strength test. It was observed that mucoadhesive
strength is significantly higher for colon than intestine part for both systems (SD and FD),
which in this case, they successfully modified the drug release system to lower residence
time in the intestine and extend release time on the colon. Several notes were considered:
(1) Contact time was found to be vital for increasing the mucoadhesive strength, and (2) A
contrary result to the statement of mucoadhesive strength is in line with the chain flexibility
structure and polar functional groups were observed. Spray-dried tablets provide better
mucoadhesive than freeze-dried, but their characteristic shows a structured, firm, and
stable tablet based on the rheological and swelling studies.
3.2.2. Gum-Based PECs for Transdermal Delivery
Similarly, transdermal delivery presents an interesting alternative to oral delivery
because the prolonged drug release reduces dosing frequency, retaining plasma levels
owing to slower release late. In the situational occasion when oral administration creates
serious side effects due to higher peak plasma levels and low drug bioavailability (caused
by the narrow therapeutic window, low drug solubility, and first-pass metabolism), trans-
dermal delivery is the best option to deliver the drug [88]. Recently, gum-based PECs were
studied to develop a different formulation for drug delivery in wound healing, primarily
in the form of membrane and hydrogel microspheres. Several studies have confirmed
biocompatibility, biodegradability, moist nature, low toxicity, prolonged drug release, and
transparency, essential for wound healing cells. However, Xanthan Gum-Chitosan hydro-
gel demonstrated the ability to support human dermal fibroblast and deliver antibiotics for
local antiseptic for acute or chronic periodontitis treatment.
Meanwhile, a similar study reported that Xanthan Gum-Chitosan hydrogel also
improved the incorporation efficiency of the low soluble drug (up to 95%) and release
(20 mg drug/g biopolymer), which slightly closed to therapeutic dosage for active wound
healing for skin lesion treatments. In another study, borate modified polyvinyl alcohol and
cationic guar-gum poly complexes with nanoparticle/nanocellulose were used as drug
carriers. This composite has efficiently improved drug encapsulation efficiency, mechanical
strength, thermal stability, skin permeability, and water vapor permeability. That system
also presented resistance to microbial growth, supporting the growth of HaCaT cells
(keratinocyte cell line from adult human skin) and negative result in skin irritation test,
which potentially affects long-term skin application [52].
3.2.3. Gum-Based PECs for Other’s Delivery Route
Facile preparation, accurate dosing, and high patience, convenience, and compliance
are considered the benefits of ophthalmic drug delivery, which are also desirable for drug
routes. Nevertheless, at the same time, poor intraocular bioavailability because of high
rates of drug dilution and elimination provoked by lacrimal flow and blinking along with
low cornea permeability become the main challenging problem for conventional eye drops.
The advancement of nanoparticles technology leads to the construction of
carboxymethyl gum katira–chitosan complexes for ophthalmic drug delivery. The ratio
adjustment of carboxymethyl gum katira–chitosan provided through Box–Behnken design
provides optimal size particle and drug encapsulation with corneal biocompatibility and
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high corneal permeability. In addition, corneal permeation was also compared with com-
mercial ofloxacin 0.3%, w/v ophthalmic solution across the porcine cornea. It was observed
that slightly higher manifest corneal permeability from nanoparticle formulation [45].
Although not so extensively, gum-based PECs were also implemented for less com-
mon delivery routes, including vaginal delivery, ophthalmic and localized drug delivery
treatment. Sonje and Mahajan (2016) developed gellan-gum-chitosan with a porous sponge-
like structure for lyophilized nasal inserts application. This system helps solve several
drawbacks of conventional liquid and powder formulation of nasal insert, which have
rapid half-life clearance, poor patient compliance, and inefficient drug dosage and delivery.
As they combined, GG as ion activated gelling polymer and chitosan with mucoadhesive
characteristic, allow several improvements in the dosing accuracy, facile way of adminis-
tration, water uptake, prolonged drug release time at the site of infection, which have been
proved by ex vivo study and in vivo study. Especially the ex vivo study demonstrated the
potential nasal delivery in enhancing bioavailability compared to oral delivery based on
New Zealand white rabbit as the animal model [49].
Cazorla-Luna et al. (2019) developed a vaginal gel formulation by combining pectin or
locust bean gum as a gelling polymer with chitosan as muco-adhesiveness for antiretroviral
drug tenofovir. As a result, the strong electrostatic interaction occurs between pectin and
chitosan in simulated vaginal fluid, creating the high gelling framework and robustly
structured with moderate swelling to prolonged the mucoadhesion residence time and
controlled drug release time up to 4 days which the time are suitable to vaginal turnover.
In addition, moderate swelling provides the guarantee of therapeutic compliance [79].
Localized cancer treatment using gum-based PECs as the matrix that sustains nanopar-
ticles and provides release control of tamoxifen citrate was reported by [58]. The hybrid
system comprising Gellan-Gum and Chitosan complexes incorporated tamoxifen citrate,
which was investigated through an in vitro cell viability study of MCF-7 (Breast Cancer
Cells). The result showed that composite induces toxic effect by increasing dosage of TMC
loaded GG/CS complexes (10–60 µg/mL) have increased the death probability of viable
cells (45.67% to 9.56%) compared to free drug-TMC suspension (53.03% to 15.54%). The
authors pointed out that the nanosized particle effectively enhances the intracellular uptake
capacity of MCF-7 while providing passive targeting and sustained drug delivery. This
phenomenon occurred due to the enhancement of permeability and retention effect. The
advantages of using nanoparticles were also demonstrated by Mahajan and Patil (2017) by
incorporating curcumin into the nano-gel composite of GG/CS complexes. They effectively
decreased the IC50 concentration from 13.6 ng/mL to 9.8 ng/mL for curcumin suspension
and curcumin-loaded nano-gel, respectively [54]. In conclusion, the formulation effectively
lowered the astrocytoma-glioblastoma cell line (U373MG) and presented hemocompatibil-
ity. In another study, gum-based PECs nanoparticles were also developed for specific target
sites for malaria chemotherapy [48] and modified by liposome coating for drug loading
and release improvement for pulmonary treatment [33].
3.2.4. Drug Release Mechanism of Gum-Based PECs
The drug release mechanism of gum-based PECs was often controlled by (i) diffusion,
(ii) degradation or erosion, (iii) solvent, or (iv) stimulus-responsive release [89,90]. In
the first case, the drug diffusion was provoked by differences in concentration gradient
across the system and carrier. Meanwhile, in the second case, the PECs matrix undergoes
degradation simultaneously as time goes by. The PECs matrix was commonly eroded from
the surface to the center, which causes the rate of degradation to be higher than solvent or
drug diffusion in/out to the matrix. For the third case, the solvent transport towards the
drug delivery system has influenced the carrier to present various drug delivery behavior.
Osmotic and swelling controlled release are the main types of solvent controlled release.
Osmotic controlled-release occurs when water flows towards the center of the carrier with
high drug concentration, passing through the permeable matrix driven by convection and
osmotic pumping. In a different system, the swelling controlled mechanism is mainly
Processes 2021, 9, 1796 19 of 29
constructed by a matrix with a three-dimensional crosslinked network structure (e.g.,
hydrogel) in which the behavior of drug release is controlled by the mesh size and its sol-
gel characteristics. In the last case, the matrix may have stimuli-responsive characteristics
that the drug release behavior induced by external stimulus, including temperature, pH,
ionic strength, ultrasound, electricity, magnetic fields, etc. gum-based PECs were advanced
for target-specific drug delivery, especially cancer, due to their possibility of localization
stimulation. The mechanism is schematically presented in Figure 3.
Processes 2021, 9, x FOR PEER REVIEW 
 19 of 30 
 
 
vent or drug diffusion in/out to the matrix. For the third case, the solvent transport to-
wards the drug delivery system has influenced the carrier to present various drug deliv-
ery behavior. Osmotic and swelling controlled release are the main types of solvent c n-
trolled release. Osmotic controlled-release occurs when water flows towards the center of 
the carrier with high drug concentration, passing through the permeable matrix driven by 
convection and osmotic pumping. In a different system, the swelling controlled mecha-
nism is mainly constructed by a matrix with a three-dimensional crosslinked network 
structure (e.g., hydrogel) in which the behavior of drug release is controlled by the mesh 
size and its sol-gel characteristics. In the last case, the matrix may have stimuli-responsive 
characteristics that the drug release behavior induced by external stimulus, including tem-
perature, pH, ionic strength, ultrasound, electricity, magnetic fields, etc. gum-based PECs 
were advanced for target-specific drug delivery, especially cancer, due to their possibility 
of localization stimulation. The mechanism is schematically presented in Figure 3. 
 
Figure 3. Schematic of drug release mechanism. 
The best way to determine the release rate and drug release profile is to compare the 
experimental findings with several iterative models. Mainly, the model prediction has 
successfully enlightened the drug release path and functional for drug release optimiza-
tion. Different models were utilized for finding the suitable mechanism for specific types 
of carriers, including zero order, first order, Higuchi, Korsmeyer–Peppas, and Peppas–
Sahlin (Table 3). The mathematical expression of various models are given as follow (NL 
and L stand for non-linear and linear equation): 
Figure 3. Schematic of drug release mechanism.
st t t r i t r l s r t r r l s r fil is t c r t
ri t l fi i it r l it r ti l . ainly, t l r i ti
s ccessf lly enlightened the drug release path and functional for drug release optimization.
Different models w re utilized for finding the suitable m chanism for specific types of
carriers, including zero o der, first o der, Higuchi, Korsmeyer–Peppas, and Peppas–Sahlin
(Table 3). Th mat matical expression of vari us m dels are given as follow (NL and
stand for on-linear a d linear equ tion):
Zero Order Equation : (L) : Qt = Q0 + k0t (1)
First Order Equation : (NL) : Qt = Q0 · e−k1t (2)




Higuchi Model : (NL) = Qt =
√
D(2C− Cs)Ct (4)
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Simplified Higuchi : (L) : Qt = kH
√
t (5)









= log kkp + n log t (7)
Peppas–Sahlin : (NL) :
Mt
M0
= kdtm + krt2m (8)
where Qt represents the amount of drug released during the time t, Q0 is the initial
amount of drug release. Parameters K0 and k1 are the zero-order and first-order constants,
respectively. In the non-linear Higuchi model, Q is the amount of drug released on time
t by area unit, C is the initial amount of drug contained in dosage form, CS is the drug
solubility in the matrix medium, and D is the coefficient of diffusion in the matrix medium.
In the linear model, Qt and kH represent the drug release amount during the time t and
the Higuchi kinetic constant, respectively. In the Korsmeyer Peppas model, Mt/M0 stands
for fractional drug release at time t, while Kkp is the specifics constant for each structural
modification and geometrical characteristic of the system (also defined as constant release
rate). Parameter n is the release exponent (correspond to the mechanism of drug release)
as a function of time t. Parameters kd and kr in the Pepper and Sahlin model stand for the
constant release rate of diffusion and polymer relaxation.
Table 3. Summary of mathematical drug release model gum-based PECs.
Gum-Based PECs Drug Model Carrier Form Suitable Model
Xanthan Gum-Chitosan
(Spray Dried)/Liposomes C-phycocyanin Hydrogel
Tablets [26]









kondagogu-chitosan Ofloxacin Nanoparticles [35]
Higuchi
(Diffusion controlled Release)
Xanthan gum-Chitosan Pediococcus acidilactici cells Hydrogel microcapsules [39]
Korsmeyer Peppas




Xanthan Gum-Chitosan Theophylline (Th)
Tablet [40]
Korsmeyer Peppas
(0.45 < n < 0.89—anomalous or
non-Fickian release)
Pepper and Sahlin (4 h-polymer




(0.45 < n < 0.89—anomalous or
non-Fickian release)
Pepper and Sahlin (2–12 h
diffusional release mechanism)
Carboxymethyl gum




Gellan Gum-Chitosan OndasetronHydrochloride Solid Dosage [49]
Korsmeyer Peppas
(0.5 < n < 1—anomalous
(non-Fickian) transport)
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Table 3. Cont.




(Mixing charge ratio n+/n− 5) Chloroquine Nanoparticles [48]





weight) (mixing charge ratio
n+/n− 0.1)
Gellan Gum-Chitosan Curcumin Nanogel [54]
Korsmeyer Peppas
(0.5 < n < 1-anomalous
(non-Fickian) transport)
Gum Ghatti-Chitosan Paracetamol Tablets [56]
Zero Order Equation (drug
release independent to
paracetamol concentration)
Xanthan Gum-Chitosan Chlorhexidine (CHX) Hydrogel Microspheres [53]
Korsmeyer Peppas




acid (HCl) solution (pH 5.6)
Ibuprofen




(0.5 < n < 1-anomalous
(non-Fickian) transport)Ibuprofen
(mass ratio of gum-based
PECs: Drug (1:2))
Xanthan Gum-Chitosan
(prepared in Acetic Acid (AA)
(pH 5.6)
Ibuprofen
(mass ratio of gum-based
PECs: Drug (1:1))
Ibuprofen
(mass ratio of gum-based
PECs: Drug (1:2))
The zero-order kinetics describes the drug release as time-dependent, and the process
takes place at a constant rate independent of drug concentration while the first-order
kinetics present contrarily. Both release model has distinctive release profile which the
first-order release often represents the initial burst release effect while zero-order releases
successfully predicted a sustained or slowed drug release profile. For instance, Lal et al.
(2017) successfully construct PECs based on in situ formation through the combination
of chitosan and xanthan gum, gum ghatti as polycation, and polyanion, respectively. A
sustained and slowed drug release was observed in simulated gastric fluid (pH 1.2, HCl
0.1 M) [56]. In a different formulation, Lankalapalli and Kolapalli (2012) reported the
drug release profile in gum karaya–chitosan PECs were fitted in the first drug release
model with over 90–99% of release in 6–12 h under phosphate buffer simulated fluid
(pH 7.4). The disintegration of tablets causes the rapid release during dissolution, which
causes the failure of matrix gel network formation in the compressed PECs, leading to less
cohesiveness of swollen matrix. As observed, the pH release medium is one of the main
aspects of altering the release drug profile, which correlates with the gelling and swelling
ability of gum-based PECs [31].
Higuchi presents the theoretical mathematical models of the release of drugs from
various matrix systems. The developed mathematical model is related to actively dispersed
particles in the homogenous matrix. Several factors such as lipophilic diffusion, planar
matrix, and homogenous system are considered in the Higuchi model [91]. Higuchi
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model can be simplified (Eq. 4) through several assumptions: (1) Higher initial drug
concentration contained in the matrix compared to the drug solubility; (2) Unidirectional
diffusion owing to negligible edge effect; (3) The molecular drug size must be lower than
the dosage form thickness; (4) drug diffusivity constant; (5) Negligible swelling or matrix
dissolution; (6) Achieving perfect sink condition in the release environment [92]. The
simplified Higuchi model representing a linear function related to the drug’s concentration
is proportional to the square root of time. In most drug release profiles in/on gum-based
PECs, the Higuchi model cannot describe the release data well since their structures have
the swelling characteristic. However, on some occasions, the Higuchi model could also
describe the release of drugs from PECs, as reported by [35,45].
A semi-empirical model named power law was developed by Korsmeyer et al. (1983)
and Ritger and Peppas (1987). This power-law model helps analyze the unknown release
mechanism or more than one drug release phenomenon (Equations (6) and (7)) [90,93,94].
The utilization of this method must comply with the assumptions: (1) One direction of
drug release; (2) width and thickness ratio ≤ 1:10 [95]. The estimated “n” value determines
the types of release mechanisms that govern the drug release profile. For easy reference,
the classification of interpretation of n in different geometrical systems summarized by
Bruschi (2015) is given in Table 4.








Function of n in Terms
of Time Variable
Fickian Diffusion





Planar (Thin Films) 0.5 < n < 1.0 t0.5 < n < 1.0
Cylinders 0.45 < n < 0.89 t0.45 < n < 0.89
Sphere 0.43 < n < 0.85 t0.43 < n < 0.85
Case I Transport





Planar (Thin Films) n > 1 tn > 1
Cylinders n > 0.89 tn > 0.85
Sphere n > 0.85 tn > 0.85
Korsmeyer–Peppas have successfully defined the mechanism of several gum-based
PECs release systems which suitable in Fickian diffusion (case I) [26], anomalous trans-
port [40,49,53,72], a super-II transport mechanism [39,48]. In the Fickian diffusion, drug
release was governed by the diffusion mechanism since the solvent transport rate or diffu-
sion rate is higher than the polymer chain relaxation. Meanwhile, the release mechanism
correlated anomalous transport when the velocity of solvent diffusion and polymer chain
relaxation exhibited similar magnitude. For the super-II transport mechanism, the solvent
diffusion of velocity is significantly higher than Fickian diffusion, accelerating solvent
diffusion penetration [97]. It is recommended to use the release curve’s portion data until
the point reaches Mt/M0 < 0.6 to provide the best solution of n value.
Peppas and Sahlin develop a model to determine the two contribution mechanisms
of diffusional and relaxational in the anomalous drug release process [98]. As present in
Equation (8), the coefficient of “m” stands for purely Fickian diffusion exponent for any
geometrical shape for various controlled release systems related to coefficient n of power
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flaw for any shapes, including films cylinder and spheres. In this case, the contribution
of the relaxation mechanism is negligible since the functional of tm is expressed as the
diffusional mechanism, while the relaxation mechanism is presented as a function of t2m.
The fraction released (Mt/M0) at time t can be investigated by comparing different models
(Korsmeyer–Peppas and Peppas–Sahlin) to justify which mechanism contributes to the
release system.
Li et al. (2014) studied the influence of the drug release mechanism of theophylline
(slightly soluble) and metoprolol succinate (free soluble) as model drugs in chitosan-
anionic gum-based tablet with SGF followed by SIF as the release medium. Based on the
Korsmeyer–Peppas model, the CS-XG system for both drugs presents coupled Fickian
diffusion–polymer relaxation mechanisms or Fickian diffusion–erosion m as a controlled
mechanism [40]. For the initial four h, the theophylline release mechanism was governed
by polymer relaxation or polymer erosion, while metoprolol succinate (free soluble) release
was controlled by diffusion and polymer swelling. In the equilibrium stage (12 h), the
theophylline release profiles were mainly controlled by diffusional drug transport since
the swelling and erosion rate reach equilibrium after 12 h. Meanwhile, the tablet matrix
maintains the diffusional release controlled for metoprolol succinate since the release
profile was affected by the large concentration gradient in the swelling matrix due to the
solubility features of drugs. It can be concluded that anionic polymers and solubility of the
characteristic of the drug are the keys to modulation drug release [40].
Not only to determine the mechanism, but the studies mentioned above also present
that these modeling systems help evaluate the effect of several aspects such as shape, size,
molecular weight, PECs composition, types of drug, etc. Shao et al. (2015) investigated
the drug release behavior from tablet matrix-based chitosan as polycation and various
polyanionic polymers. It was found that the strength and permeability of PECs on the
tablet’s surface could be modulated by changing the anionic of gum. In vitro drug release
in simulated gastric fluid revealed the combination of chitosan and xanthan gum provides
sustained-release rate up to 24 h for highly soluble drug (sodium valproate and valproic
acid mixture) with erosion and swelling controlled mechanism [43]. In addition, it was
also observed that changing the ratio of xanthan gum and chitosan and modulating the
molecular weight of chitosan unaffected the rate of drug release. Based on the previous
study, the presence of PECs-film on the tablet’s surface hindered the matrix erosion and
swelling, which further prolonged drug release and changed the anionic gums, which
provide different gel strength, modulating the erosion capacity of the tablet [40].
The selection of optimal acid preparation of gum-based PECs and initial pH value is
crucial in modulating the release rate and mechanism of the drug from the solid carrier. As
presented by Ćirić et al. (2020), with the increasing pH of acetic acid and HCl, the strength
of the solid drug’s physical (ionic, hydrogen bonds) interactions decreased, increasing the
swelling capacity and hindrance the ibuprofen release and dissolution in phosphate buffer.
The authors notified that the alteration in the release rate of ibuprofen corresponded to the
different thixotropy characteristics of each type of tablet after rehydration in phosphate
buffer [72].
In nanoparticles, the carrier’s size is considered the priority of carrier features and
drug encapsulation efficiency and release. Minkal et al. (2018) reported the effect of car-
boxymethyl gum Katira and chitosan concentration on entrapment efficiency and nanopar-
ticle size prepared by the coacervation method. An increase in chitosan concentration
and a decrease in the viscosity of CMGK create the smallest nanoparticle size with high
entrapment efficiency [57]. Based on the in vitro release study, the carriers were prolonged
drug release up to 24 h with 50% release. The drug release could be described by the
Higuchi model (diffusion governed mechanism). A similar result was also demonstrated
by Kumar and Ahuja (2013). In another study, Magalhães Jr. et al. (2016) reported that
the molar ratio of positive to negative charges, mixing order of polyelectrolytes, and total
polymer concentration affect the particle size of gum-based PECs nanoparticle (chitosan
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and rhamnogalacturonoglycan) [48]. Meanwhile, the charge ratio of PECs was observed to
control the release rate of chloroquine for up to 12 days.
4. Future Perspective
In recent decades, the number of publications on gum-based PECs for biomedical engi-
neering applications has risen, particularly for drug delivery, tissue and bone regeneration
applications. The growing number of papers on the use of Gum PECs is a clear indicator of
the material’s possible future applications (as indicated in Figure 4). Several reviews and
research papers have evaluated the phenomenon of polyelectrolyte complexation between
polymers of opposite charge leads to the creation of polymeric carriers which capable of
regulating the initial burst as well as the following sustained release of loaded from carrier
forms. This might be owing to the high order degree and crystal-like compact structures of
synthesized polymeric carriers [56]. Gum hydrocolloids and their modification have ex-
hibited tremendous promise as one of the polyanionic sources in drug carrier formulation.
Despite their biodegradability and biocompatibility, their opposite charged partner also
plays a significant role such as chitosan in ameliorating the mucoadhesive characteristics.
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tissue engineering and drug delivery. Researchers should pursue this as an active field of
research and conduct further in vivo experiments to back up and reinforce the present find-
ings. In particular, most reviewed studies of gum-based PECs for drug delivery excluded
in vivo experiments which regrettably, since the human body has a complex digestion
system [99]. Several materials such as 1D carbon nanotubes/2D nanomaterials can be
potential candidates as additional material for gum PECs composite owing to their inter-
esting features such as high mechanical characteristic which advantageous to refine the
biological and scaffolds mechanical characteristics while also ameliorate the disadvantages
of both materials [100,101]. With the sophistication of nanotechnology, it is highly expected
to develop economically and non-toxic scaffolds and carriers in the near future through
various natural gums and inorganic and organic substances blending.
5. Conclusions
Natural gums are widely applied in food formulation and pharmaceutical applications.
Functionalization with other polymers is usually conducted to enhance their capability in
various applications. The combination of gums with other natural polymers and chitosan
to form polyelectrolyte complexes (PEC) are widely studied. Gum hydrocolloid polyelec-
trolyte complexes (PECs) have potential application in drug delivery systems. The pH
and the ratio of polymers strongly affect the formation of PECs. The mechanism of PECs
formation is based on the electrostatic interaction of two oppositely charged polymers. The
ratio of polyanion and polycation also influence the particle size and mechanical properties
of PECs. Besides being used for the diverse oral delivery formulation, gum-based PECs
were also widely developed for peroral drug delivery, transdermal delivery, ophthalmic
drug delivery, vaginal delivery, and localized drug delivery treatment. The combination of
natural gums with other nanoparticles has a significant challenge in biomedical applica-
tions and tissue engineering. Several characteristics such as rate of material disintegration,
porosity, interconnecting pore framework, and structural homogeneity are still a challenge
for using PECs as a scaffold for supporting cell growth.
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